Research Topics
| Rochelle E CurtisSummaryAffiliation: National Institutes of Health Country: USA Publications
| Collaborators
|
Detail Information
Publications
Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort studyBassam Ghabach
Department of Veterans Affairs Medical Center, Medical Service 111, 921 NE 13th Street, Oklahoma City, OK 73104, USA
Breast Cancer Res 12:R54. 2010..We sought to provide new population-based information on breast-ACC incidence, relative survival, and associated cancer risk in the United States...- Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control studyRochelle E Curtis
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Executive Plaza South, Suite 7042, 6120 Executive Blvd, Bethesda, MD 20892, USA
Blood 105:3802-11. 2005..Our results also suggest that clinical screening for SCC is appropriate among patients exposed to persistent chronic GVHD, prolonged immunosuppressive therapy, or both... 
Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancerRochelle E Curtis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892 7362, USA
J Natl Cancer Inst 96:70-4. 2004..These findings indicate that tamoxifen may have delayed effects, such as the increased risk of MMMTs, rare but aggressive tumors of unclear pathogenesis...- Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancerStefan Lonn
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland, USA
Cancer Epidemiol Biomarkers Prev 19:464-74. 2010..Adjuvant radiotherapy is common for uterine corpus cancer patients, yet the long-term carcinogenic effects of different types of radiotherapy have not been studied adequately... - Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factorsDeirdre A Hill
Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
Blood 106:3358-65. 2005..The additional increased relative risk of breast cancer after RT for HL is unlikely to be larger among women with a family history of breast or ovarian cancer than among other women... - Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control studyCatherine Metayer
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
Blood 101:2015-23. 2003..Transplantation-related factors may also modulate this risk; however, the apparent contribution of high-dose TBI requires confirmation... - Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registriesAmy Berrington de Gonzalez
Radiation Epidemiology Branch, National Cancer Institute, Bethesda, MD 20892, USA
Lancet Oncol 12:353-60. 2011..We aimed to estimate the proportion of second cancers attributable to radiotherapy in adults with data from the US Surveillance, Epidemiology and End Results (SEER) cancer registries... - Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantationOla Landgren
Division of Cancer Epidemiology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
Blood 113:4992-5001. 2009..Our findings identify subgroups of patients who underwent allogeneic HCT at elevated risk of PTLDs for whom prospective monitoring of Epstein-Barr virus activation and early treatment intervention may be particularly beneficial... - Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 yearsGraca M Dores
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Executive Plaza South, Suite 7039, Bethesda, MD 20892, USA
J Clin Oncol 20:3484-94. 2002.... - Risk of radiation-related salivary gland carcinomas among survivors of Hodgkin lymphoma: a population-based analysisHouda Boukheris
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
Cancer 113:3153-9. 2008..Radiotherapy for Hodgkin lymphoma (HL) increases the risk of salivary gland carcinomas (SGC). To the authors' knowledge, however, the magnitude of the risk has not been assessed to date... - Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtypeLindsay M Morton
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD 20892, USA
J Clin Oncol 28:4935-44. 2010.... - Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United StatesHouda Boukheris
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute NIH, Bethesda, Maryland, USA
Cancer Epidemiol Biomarkers Prev 18:2899-906. 2009..Carcinomas of the major salivary glands (M-SGC) comprise a morphologically diverse group of rare tumors of largely unknown cause. To gain insight into etiology, we evaluated incidence of M-SGC using the WHO classification schema (WHO-2005)... - Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiologyGraca M Dores
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services DHHS, National Cancer Institute NCI, National Institutes of Health NIH, Bethesda, MD, USA
Br J Haematol 139:809-19. 2007..Avenues of future research include assessment of delayed- and under-reporting to cancer registries and exploration of race, gender, and age effects in epidemiological studies... - Merkel cell carcinoma and multiple primary cancersRegan A Howard
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, MD 20892 7238, USA
Cancer Epidemiol Biomarkers Prev 15:1545-9. 2006..Heightened awareness of the associations of lymphohematopoietic malignancies with MCC may facilitate early clinical recognition... - The risk of developing second cancers among survivors of childhood soft tissue sarcomaRandi J Cohen
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
Cancer 103:2391-6. 2005..CONCLUSIONS: The risk of second malignancies was increased for all histologic types of childhood STS and was particularly high among patients who received combined modality therapy... - Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndromeGraca M Dores
Medical Service, Department of Veterans Affairs Medical Center, Oklahoma City, OK 73104, USA
Cancer 113:3372-81. 2008..To the authors' knowledge, only limited information exists regarding incidence patterns of sebaceous carcinoma (SC), and no prior study has quantified risks of associated cancers... - Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004Graca M Dores
Department of Veterans Affairs Medical Center, Medical Service, Oklahoma City, OK 73104, USA
Br J Haematol 144:86-94. 2009..Five-year relative survival for P-bone, P-extramedullary, and MM varied significantly by age (<60/60+ years), supporting age-related differences in disease burden at presentation, disease biology, and/or treatment approaches... - The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor statusSara J Schonfeld
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA
Cancer Causes Control 23:1721-8. 2012..It is unknown whether second lung cancer risk varies by estrogen receptor (ER) expression of the first breast cancer... - New malignancies following childhood cancer in the United States, 1973-2002Peter D Inskip
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD, USA
Int J Cancer 121:2233-40. 2007.... - Risk of subsequent cancer following breast cancer in menAnssi Auvinen
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892-7362, USA
J Natl Cancer Inst 94:1330-2. 2002..We conclude that men diagnosed with breast cancer are at high risk of contralateral breast cancer... - Lung cancer following chemotherapy and radiotherapy for Hodgkin's diseaseLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
J Natl Cancer Inst 94:182-92. 2002..We quantified the risk of treatment-associated lung cancer, taking into account tobacco use... - Prostate radiotherapy is associated with second cancers in many organs, not just the colorectumDavid J Brenner
Gastroenterology 129:773-4; author reply 774-5. 2005 - Assessment of delayed reporting of mycosis fungoides and Sezary syndrome in the United StatesGraca M Dores
Arch Dermatol 144:413-4. 2008